Northland Capital Markets Remains Bullish on Wright Medical Group (WMGI) Following AUGMENT FDA Approval
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Wright Medical Group, Inc. Announces FDA Approval for AUGMENT(R) Bone Graft
September 1, 2015 4:00 PM EDTFirst Clinically Proven, Cost-Effective Alternative to Autograft for Ankle and/or Hindfoot Fusion Indications
Company Can Now Initiate Commercial Sale and Distribution of AUGMENT® Bone Graft in the U.S.
MEMPHIS, Tenn., Sept. 01, 2015 (GLOBE NEWSWIRE) -- Wright Medical Group, Inc. (NASDAQ: WMGI) today announced that its BioMimetic subsidiary has received an approval order from the U.S. Food and Drug Administration (FDA) for its Premarket Approval Application (PMA) for AUGMENT® Bone Graft. The approval order indicates that FDA determined... More
